Clearside Biomedical Inc. News
Clearside Jumps; Wedbush Triples Target After Eye-Drug Trial Progress
Wedbush raised its price target on Clearside after the company reported progress in a clinical trial of CLS-AX, which treats age-related macular degeneration.
5 Top Stock Gainers for Tuesday: Exxon Mobil, Del Taco, Ocugen
Exxon Mobil, Del Taco Restaurants, Ocugen, Clearside Biomedical and Torchlight Energy Resources are five top gainers for Tuesday.
Clearside Biomedical Soars; Roth Capital Calls Eye Drug 'Game Changer'
Clearside Biomedical rises as a Roth Capital analyst says the company's eye treatment test results are 'a game changer.'
Biotech Premarket Movers: Impax, Clearside Biomedical, Mylan
Impax Laboratories, Clearside Biomedical and Mylan were among the biotech stock movers in premarket trading Wednesday.
Biotech premarket movers: Pacira, Clearside Biomedical and Organovo
Pacira Pharmaceuticals, Clearside Biomedical and Organovo Holdings are among the premarket biotech movers on Wednesday.
Breaking News
UnitedHealth Group Stock Edges Lower On Muted 2023 Profit Forecast
UnitedHealth, a Dow component, will host it annual investor event later today in New York.
Roku Stock Slides As KeyBanc Cuts Rating to 'Sector Weight' On Ad Weakness
Roku's eroding market share, and its need for new investment, will pressure near-term profits, according to KeyBanc analyst Justin Patterson.
Tesla Sentiment, Fundamentals Affected By Musk's Twitter Purchase - Morgan Stanley Survey
“Our investor survey reinforces our views that Elon Musk's recent involvement with Twitter has contributed to negative sentiment momentum in Tesla shares," said Morgan Stanley analyst Adam Jonas.
'Un-carrier' T-Mobile Makes a Very Verizon, AT&T 'Carrier' Move
Mobile carrier companies are always eager to increase revenue through fees customers pay and to outflank their competition with deals.